Table 2

Correlations* between patients’ self-assessment of SLE disease activity and physician’s assessment (n=115)

	Coefficient*	P value
SLAM-nolab versus
Total Q-SLAQ	0.709	<0.001
Total Q-SLAQ with sicca	0.690	<0.001
Symptom Score	0.680	<0.001
Symptom Score with sicca	0.674	<0.001
Patient’s global disease activity	0.683	<0.001
SLAM versus
Total Q-SLAQ	0.528	<0.001
Total Q-SLAQ with sicca	0.505	<0.001
Symptom Score	0.496	<0.001
Symptom Score with sicca	0.488	<0.001
Patient’s global disease activity	0.529	<0.001
SLEDAI-2K nolab versus
Total Q-SLAQ	0.303	0.001
Total Q-SLAQ with sicca	0.274	0.004
Symptom Score	0.301	0.001
Symptom Score with sicca	0.292	0.002
Patient’s global disease activity	0.361	<0.001
SLEDAI-2K versus
Total Q-SLAQ	−0.046	0.622
Total Q-SLAQ with sicca	−0.084	0.371
Symptom Score	−0.028	0.766
Symptom Score with sicca	−0.042	0.656
Patient’s global disease activity	0.086	0.374

*Spearman correlation.
Q-SLAQ, Quick Systemic Lupus Activity Questionnaire; SLAM, SLE Activity Measure; SLAM-nolab, Systemic Lupus Activity Measure without laboratory parameters; SLEDAI-2K, SLE Disease Activity Index; SLEDAI-2K-nolab, SLE Disease Activity Index without laboratory parameters.